RHYAN PENSA: Open Payments
NPI 1073210035 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,409 in 66 payments from 25 companies in 2025. Trend: 2023 $858 · 2024 $1,137 · 2025 $1,409
Food & beverage: $1,309Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 16 | $236 |
| Janssen Biotech, Inc. | 6 | $213 |
| ABBVIE INC. | 6 | $108 |
| Ferring Pharmaceuticals Inc. | 3 | $78 |
| Blue Earth Diagnostics | 3 | $76 |
| PFIZER INC. | 3 | $61 |
| Dendreon Pharmaceuticals LLC | 2 | $56 |
| Antares Pharma, Inc. | 3 | $55 |
| Olympus America Inc. | 3 | $51 |
| UROGEN PHARMA, INC. | 2 | $51 |
Products named: ERLEADA, GEMTESA, BOTOX, ADSTILADRIN, Xtandi, POSLUMA, PROVENGE, XYOSTED.
Industry payments across MI — which companies pay providers there.
